Century Therapeutics is a biotechnology company focused on developing advanced cell therapies using induced pluripotent stem cells (iPSCs) to treat hematologic and solid tumors. Founded in 2018 and headquartered in Philadelphia, Pennsylvania, the company utilizes a genetically engineered platform that includes CRISPR-mediated gene editing and proprietary chimeric antigen receptors to create allogeneic immune effector cell products. These innovations are designed to specifically target various cancers while minimizing the risk of rejection by the host immune system. By expanding and differentiating master cell banks of modified iPSCs, Century Therapeutics aims to provide homogeneous therapeutic products that enhance cancer care, offering new hope for patients facing cancer and other serious diseases.
Empirica Therapeutics is a biotechnology company that develops therapeutic drugs aimed at treating aggressive forms of cancer. The company specializes in creating adoptive immunotherapies targeting highly resistant cancers, particularly glioblastoma and brain metastasis. By focusing on these challenging malignancies, Empirica Therapeutics seeks to provide improved treatment options for patients facing significant unmet medical needs in the oncology landscape.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.